GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (BUE:BMY) » Definitions » Construction In Progress

Bristol-Myers Squibb Co (BUE:BMY) Construction In Progress : ARS1,021,953 Mil (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Bristol-Myers Squibb Co Construction In Progress?

Bristol-Myers Squibb Co's quarterly construction in progress declined from Sep. 2023 (ARS389,844 Mil) to Dec. 2023 (ARS388,075 Mil) but then increased from Dec. 2023 (ARS388,075 Mil) to Mar. 2024 (ARS1,021,953 Mil).

Bristol-Myers Squibb Co's annual construction in progress increased from Dec. 2021 (ARS77,156 Mil) to Dec. 2022 (ARS176,535 Mil) and increased from Dec. 2022 (ARS176,535 Mil) to Dec. 2023 (ARS388,075 Mil).

Bristol-Myers Squibb Co Construction In Progress Historical Data

The historical data trend for Bristol-Myers Squibb Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Construction In Progress Chart

Bristol-Myers Squibb Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31,500.69 39,632.06 77,156.36 176,535.45 388,075.00

Bristol-Myers Squibb Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 212,168.71 287,280.00 389,844.31 388,075.00 1,021,952.52

Bristol-Myers Squibb Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Bristol-Myers Squibb Co (BUE:BMY) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (BUE:BMY) » Definitions » Construction In Progress
Comparable Companies
GILD PFE AMGN BIIB OGN AMRN SCLX MIRA ABBV MRK LLY JNJ LSE:AZN XSWX:NOVN XSWX:ROG XPAR:SAN LSE:GSK TSE:4568 TSE:4519 SHSE:600276
Traded in Other Exchanges
BMYMP.PFD:USA BMY:USA BMY:Peru BMY:Mexico 1BMY:Italy BRMd:UK 0R1F:UK BRM:Germany BMYB34:Brazil BMYS:Austria
Address
430 East 29th Street, 14th Floor, New York, NY, USA, 10016
Website
https://www.bms.com
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.